Valentina Iannizzotto
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Podoplanin expressing macrophages and their involvement in tertiary lymphoid structures in mouse models of Sjögren's disease.
Journal: Frontiers in immunology
Published: June 26, 2024
Molecular and spatial analysis of tertiary lymphoid structures in Sjogren's syndrome.
Journal: Nature communications
Published: October 20, 2022
Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren's syndrome.
Journal: Arthritis research & therapy
Published: March 03, 2021
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction.
Journal: Communications biology
Published: June 01, 2020
Autophagy occurs in lymphocytes infiltrating Sjögren's syndrome minor salivary glands and correlates with histological severity of salivary gland lesions.
Journal: Arthritis research & therapy
Published: April 28, 2020
Leflunomide-hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial.
Journal: The Lancet. Rheumatology
Published: January 08, 2020
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 20, 2019
CXCL13 as biomarker for histological involvement in Sjögren's syndrome.
Journal: Rheumatology (Oxford, England)
Published: December 12, 2018
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.
Journal: Annals of the rheumatic diseases
Published: October 30, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026